Hepato-pancreato-biliary
Ace St. John, MD, MS (he/him/his)
Resident Physician
University of Maryland Medical Center, United States
Ace St. John, MD, MS (he/him/his)
Resident Physician
University of Maryland Medical Center, United States
Jason W. Denbo, MD
GI/HPB Surgeon
Moffitt Cancer Center
Tampa, Florida, United States
Jenny B Permuth, PhD
GI Oncology
Moffitt Cancer Center, United States
Susan T. Vadaparampil, PhD, MPH
Professor
Moffitt Cancer Center, United States
Cheryl Knott, PhD
Professor, behavioral and community health
University of Maryland, United States
Daniel A. Anaya Saenz, MD, MSHCT
GI Oncology
Moffitt Cancer Center
Tampa, Florida, United States
Jason B. B. Fleming, MD (he/him/his)
GI Oncology
Moffitt Cancer Center, United States
Benjamin Powers, MD
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
University of Maryland, United States
The study found a median national SED ranking of 64, with a median follow-up time of 22.1 months. The treatment rates were 77.5% for no procedural treatment, 11.2% for hepatectomy, and 11.3% for transplant. The median OS stood at 14.6, 48.4, and 97.4 months for no procedural treatment, hepatectomy, and transplant, respectively (p< 0.05). When comparing the lowest and highest SED quintiles, the median OS was 24.4 and 18.9 months respectively (p< 0.05). In cases of hepatectomy or transplant, no significant OS difference was found between the lowest and highest SED quintiles (64.4 and 61.6 months, respectively). However, post demographic and treatment variables adjustment, a higher mortality rate was observed in the highest SED quintile compared to the lowest (HR 1.19; 95% CI,1.05-1.37).
Conclusions: The findings reveal that in Florida, early-stage HCC patients from higher SED neighborhoods are less likely to receive treatment and have poorer overall survival rates compared to those from lower SED neighborhoods. This OS disparity remained even after accounting for demographic and treatment variables, highlighting a pressing need to further explore the impact of SED on the HCC cancer continuum.